Ovid and Angelini Enter into Exclusive License Agreement to Develop, Manufacture and Commercialize OV101 Read more
Revitope And Junshi Enter Into Research Collaboration And License Agreement To Explore Next Generation Immunotherapies Read more
Merus and Caris Life Sciences Announce Collaboration to Detect NRG1 Fusions in Cancer Patients Read more
Pfizer and BioNTech Granted FDA Fast Track Designation for Two Investigational mRNA-based Vaccine Candidates Against SARS-CoV-2 Read more
New data from phase IIIb study reinforces safety profile of Roche’s Hemlibra in people with haemophilia A Read more
Roche provides update on Phase III study of Tecentriq in women with advanced stage ovarian cancer Read more
Mylan and Fujifilm Kyowa Kirin Biologics Announce U.S. FDA Approval of Hulio (adalimumab-fkjp) Read more